SHANGHAI, March 30, 2026 /PRNewswire/ — WuXi Biologics (“WuXi Bio”) (2269.HK), a number one international Contract Analysis, Growth and Manufacturing Group (CRDMO), introduced that it has gained “Biologics CDMO of the Yr” (Giant CDMOs) within the 2026 CDMO Management Awards. The corporate has additionally been acknowledged for excellence throughout a number of classes for “Giant CDMO Biologic”, together with “Finest Scaling Assist”, “Finest Analytical Providers”, “Finest General Workers”, and “Finest Mission Administration”. These achievements mark WuXi Biologics’ ninth consecutive 12 months successful the CDMO Management Awards, underscoring its dedication to advancing built-in expertise platforms that speed up biologics discovery, growth, and manufacturing. Dr. Chris Chen, CEO of…
Elevate your perspective with NextTech Information, the place innovation meets perception.
Uncover the most recent breakthroughs, get unique updates, and join with a worldwide community of future-focused thinkers.
Unlock tomorrow’s traits right this moment: learn extra, subscribe to our publication, and grow to be a part of the NextTech neighborhood at NextTech-news.com
